| CD8+ T Cells in Facioscapulohumeral Muscular Dystrophy Patients with Inflammatory Features at Muscle MRI G Frisullo, R Frusciante, V Nociti, G Tasca, R Renna, R Iorio, AK Patanella, ... Journal of clinical immunology 31, 155-166, 2011 | 142 | 2011 |
| The effect of disease activity on leptin, leptin receptor and suppressor of cytokine signalling-3 expression in relapsing–remitting multiple sclerosis G Frisullo, M Mirabella, F Angelucci, M Caggiula, R Morosetti, ... Journal of neuroimmunology 192 (1-2), 174-183, 2007 | 96 | 2007 |
| Comorbidities, cardiovascular therapies, and COVID-19 mortality: a nationwide, Italian observational study (ItaliCO) F Polverino, DA Stern, G Ruocco, E Balestro, M Bassetti, M Candelli, ... Frontiers in cardiovascular medicine 7, 585866, 2020 | 81 | 2020 |
| SARS‐CoV‐2 infection and venous thromboembolism after surgery: an international prospective cohort study COVIDSurg Collaborative, GlobalSurg Collaborative, D Nepogodiev, ... Anaesthesia 77 (1), 28-39, 2022 | 59 | 2022 |
| No evidence of disease activity (NEDA-3) and disability improvement after alemtuzumab treatment for multiple sclerosis: a 36-month real-world study L Prosperini, P Annovazzi, L Boffa, MC Buscarinu, A Gallo, M Matta, ... Journal of neurology 265, 2851-2860, 2018 | 55 | 2018 |
| Real-world effectiveness of natalizumab and fingolimod compared with self-injectable drugs in non-responders and in treatment-naïve patients with multiple sclerosis L Prosperini, F Saccà, C Cordioli, A Cortese, F Buttari, S Pontecorvo, ... Journal of neurology 264, 284-294, 2017 | 54 | 2017 |
| Epstein-Barr virus antibodies in serum and cerebrospinal fluid from multiple sclerosis, chronic inflammatory demyelinating polyradiculoneuropathy and amyotrophic lateral sclerosis V Nociti, G Frisullo, A Marti, M Luigetti, R Iorio, AK Patanella, A Bianco, ... Journal of neuroimmunology 225 (1-2), 149-152, 2010 | 51 | 2010 |
| Increased CD4+ CD25+ Foxp3+ T cells in peripheral blood of celiac disease patients: correlation with dietary treatment G Frisullo, V Nociti, R Iorio, AK Patanella, A Marti, B Assunta, D Plantone, ... Human immunology 70 (6), 430-435, 2009 | 50 | 2009 |
| Fingolimod vs dimethyl fumarate in multiple sclerosis: a real-world propensity score-matched study L Prosperini, M Lucchini, S Haggiag, P Bellantonio, A Bianco, ... Neurology 91 (2), e153-e161, 2018 | 43 | 2018 |
| Circulating CD56dim NK cells expressing perforin are increased in progressive multiple sclerosis D Plantone, A Marti, G Frisullo, R Iorio, V Damato, V Nociti, AK Patanella, ... Journal of neuroimmunology 265 (1-2), 124-127, 2013 | 40 | 2013 |
| Glucocorticoid treatment reduces T-bet and pSTAT1 expression in mononuclear cells from relapsing remitting multiple sclerosis patients G Frisullo, V Nociti, R Iorio, AK Patanella, A Bianco, M Caggiula, ... Clinical Immunology 124 (3), 284-293, 2007 | 39 | 2007 |
| The disease-modifying therapies of relapsing-remitting multiple sclerosis and liver injury: a narrative review M Biolato, A Bianco, M Lucchini, A Gasbarrini, M Mirabella, A Grieco CNS drugs 35 (8), 861-880, 2021 | 38 | 2021 |
| Is serological response to SARS-CoV-2 preserved in MS patients on ocrelizumab treatment? A case report M Lucchini, A Bianco, P Del Giacomo, C De Fino, V Nociti, M Mirabella Multiple sclerosis and related disorders 44, 102323, 2020 | 38 | 2020 |
| Immunogenicity and safety of mRNA COVID-19 vaccines in people with multiple sclerosis treated with different disease-modifying therapies F Capone, M Lucchini, E Ferraro, A Bianco, M Rossi, A Cicia, A Cortese, ... Neurotherapeutics 19 (1), 325-333, 2023 | 37 | 2023 |
| Liver injury after pulsed methylprednisolone therapy in multiple sclerosis patients V Nociti, M Biolato, C De Fino, A Bianco, FA Losavio, M Lucchini, ... Brain and behavior 8 (6), e00968, 2018 | 31 | 2018 |
| T-bet, pSTAT1 and pSTAT3 expression in peripheral blood mononuclear cells during pregnancy correlates with post-partum activation of multiple sclerosis R Iorio, G Frisullo, V Nociti, KA Patanella, A Bianco, A Marti, M Mirabella, ... Clinical Immunology 131 (1), 70-83, 2009 | 29 | 2009 |
| The predictive value of CSF multiple assay in multiple sclerosis: a single center experience C De Fino, M Lucchini, D Lucchetti, V Nociti, FA Losavio, A Bianco, ... Multiple sclerosis and related disorders 35, 176-181, 2019 | 21 | 2019 |
| Second-line therapy with fingolimod for relapsing-remitting multiple sclerosis in clinical practice: the effect of previous exposure to natalizumab A Bianco, AK Patanella, V Nociti, A Marti, G Frisullo, D Plantone, ... European Neurology 73 (1-2), 57-65, 2015 | 21 | 2015 |
| Effects of THC/CBD oromucosal spray on spasticity-related symptoms in people with multiple sclerosis: results from a retrospective multicenter study F Patti, CG Chisari, C Solaro, MD Benedetti, E Berra, A Bianco, ... Neurological Sciences 41, 2905-2913, 2020 | 18 | 2020 |
| The influence of physiotherapy intervention on patients with multiple sclerosis–related spasticity treated with nabiximols (THC: CBD oromucosal spray) AE Grimaldi, L De Giglio, S Haggiag, A Bianco, A Cortese, SG Crisafulli, ... PLoS One 14 (7), e0219670, 2019 | 17 | 2019 |
